Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

2009 ◽  
Vol 55 (6) ◽  
pp. 1430-1439 ◽  
Author(s):  
Manfred Johannsen ◽  
Anne Flörcken ◽  
Axel Bex ◽  
Jan Roigas ◽  
Marco Cosentino ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Retrospective Analysis ◽  
Tyrosine Kinase Inhibitors ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Complete Response ◽  
Response To Treatment

scholarly journals Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma

2019 ◽  
Vol 30 (1) ◽  
pp. 150-151
Author(s):  
S.V. Lightowlers ◽  
B. Greef ◽  
T. Eisen ◽  
A. Matakidou ◽  
K. Fife ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document